Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG (BAYN)

186
Real-time Quote. Real-time Tradegate - 07/30 11:12:53 am
101.205 EUR   +1.73%
5h agoDJBAYER : Receives EU Approval for Stivarga for Tumor Treatment
6h agoDJBAYER : Profit Rises But Outlook Tweaked
7h agoDJBAYER : FDA Approves Bayer's Eylea for Diabetic Macular Edema Treatment
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
07/23/2014 07/24/2014 07/25/2014 07/28/2014 07/29/2014 Date
100.4(c) 100.95(c) 98.71(c) 99.29(c) 99.48(c) Last
1 279 474 1 337 923 1 635 122 1 453 034 1 665 213 Volume
+0.51% +0.55% -2.22% +0.59% +0.19% Change
More quotes
Company
Bayer AG is engaged in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the Healthcare, Crop Science and Material Science subgroups, which are supported by three service companies. The Healthcare subgroup... 
Sector
Pharmaceuticals
Calendar
07/30 | 01:30amEarnings Release
Surperformance© rating of Bayer AG
Trading Rating : Investor Rating :
More about the company
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 41 851 M
EBIT 2014 6 400 M
Net income 2014 3 993 M
Debt 2014 10 583 M
Yield 2014 2,27%
Sales 2015 44 965 M
EBIT 2015 7 325 M
Net income 2015 4 574 M
Debt 2015 10 344 M
Yield 2015 2,51%
PER 2014 20,32
PER 2015 17,85
EV / Sales 2014 2,22x
EV / Sales 2015 2,06x
Capitalization 82 265 M
More Financials
Latest news on BAYER AG
5h agoDJBAYER : Receives EU Approval for Stivarga for Tumor Treatment
6h agoDJBAYER : Profit Rises But Outlook Tweaked
7h agoDJBAYER : FDA Approves Bayer's Eylea for Diabetic Macular Edema Treatment
8h ago BAYER : results fall slightly short of view on strong euro
2d agoDJOfficials Visit Microsoft's China Offices -- Update
2d ago BAYER : Presolicitation Notice - J-- Medrad AngioJet Ultra Thrombectomy System P..
2d agoDJBAYER : 2Q 2014 -- Forecast
4d ago BAYER : Purchase of syringes for injection pump kit MEDRAD, Stellant D model to ..
5d agoDJBAYER : and Onyx Say Phase III Trial of Nexavar Breast Cancer Treatment Failed
7d ago Malini Moorthy Joins Bayer as U.S. Head of Litigation
07/22 BAYER : New Bayer plastic makes luggage lighter and more secure -- Travel more c..
07/21 Aurelius buys Scholl shoe business from Reckitt Benckiser
More news
4-Traders Strategies on BAYER AG 
07/18The EUR 100 area as entry point
05/20The EUR 104 resistance as main obstacle
More Strategies
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
Bayer AG : Income Statement Evolution
More Financials
EPS Revisions
Bayer AG : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF